NEW YORK: While suspected for some time, a study now confirms that people taking the acne drug isotretinoin appear to run an increased risk of developing inflammatory bowel disease (IBD), US researchers report.
IBD includes Crohn's disease and a similar condition called ulcerative colitis.
Isotretinoin, more familiarly known by the brand name Accutane, was first approved for acne in the US in 1982, and numerous cases have surfaced linking the drug to IBD.
Until now, a systematic review of the association had not been conducted.
